Jw Life Science Corp (234080) — Free Cash Flow Generation Index
Jw Life Science Corp (234080) has a Free Cash Flow Generation Index of 0.76x as of March 2026. Free cash flow of ₩10.71 Billion represents 1% of operating cash flow (₩14.17 Billion). Explore reinvestment intensity of Jw Life Science Corp to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jw Life Science Corp Free Cash Flow Generation Index (2015–2025)
Historical FCF Generation Index trend for Jw Life Science Corp across 11 annual periods. For the full cash flow conversion analysis, see Jw Life Science Corp cash conversion from operations.
Annual Free Cash Flow Generation for Jw Life Science Corp (2015–2025)
Year-by-year Free Cash Flow Generation Index for Jw Life Science Corp. Check total reinvestment intensity of Jw Life Science Corp to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | ₩27.10 Billion | ₩40.54 Billion | ₩13.43 Billion | ▼ -16.1% |
| 2024 | 0.80x | ₩40.38 Billion | ₩50.69 Billion | ₩10.31 Billion | ▲ +2.1% |
| 2023 | 0.78x | ₩29.31 Billion | ₩37.57 Billion | ₩8.27 Billion | ▲ +88.9% |
| 2022 | 0.41x | ₩5.84 Billion | ₩14.13 Billion | ₩8.29 Billion | ▲ +15.7% |
| 2021 | 0.36x | ₩10.77 Billion | ₩30.17 Billion | ₩18.98 Billion | ▼ -45.3% |
| 2020 | 0.65x | ₩30.52 Billion | ₩46.75 Billion | ₩15.93 Billion | ▼ -0.5% |
| 2019 | 0.66x | ₩15.92 Billion | ₩24.28 Billion | ₩8.09 Billion | ▼ -7.3% |
| 2018 | 0.71x | ₩25.57 Billion | ₩36.13 Billion | ₩10.04 Billion | ▲ +18.2% |
| 2017 | 0.60x | ₩13.20 Billion | ₩22.05 Billion | ₩8.77 Billion | ▼ -67.3% |
| 2016 | 1.83x | ₩29.45 Billion | ₩16.08 Billion | ₩13.37 Billion | ▼ -3.3% |
| 2015 | 1.89x | ₩49.03 Billion | ₩25.90 Billion | ₩23.14 Billion | — |